Komal Joshi | Investor Relations |
Rich Murray | Chief Executive Officer & President |
Beth Trehu | Chief Medical Officer |
Kim Drapkin | Chief Financial Officer |
Boris Peaker | Cowen |
Jim Birchenough | Wells Fargo |
Mike Ulz | Baird |
Aaron Welch | H.C. Wainwright |
Good morning, ladies and gentlemen, and welcome to the Jounce Therapeutics Fourth Quarter and Full year 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time.
As a reminder, this conference is being recorded at the company's request.
I will now turn the call over to your host Komal Joshi with Jounce Therapeutics.